| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |